Position in AGEN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$306
-$28 QoQ
Shares Held
100
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#93
of 103 holders
Holding Since
Mar 2022
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AGEN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Federation des caisses Desjardins du Quebec holds $61,128,046 across 154 Biotechnology names. AGEN ranks #136 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
20,094 | $9,981,291 | |
| 2 | ARGX |
Argenx SE
|
7,637 | $7,085,378 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
10,915 | $6,805,937 | |
| 4 | INCY |
Incyte Corp
|
57,354 | $6,501,647 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
16,951 | $3,174,581 | |
| 6 | MRNA |
Moderna, Inc.
|
41,572 | $2,911,286 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
8,591 | $2,586,147 | |
| 8 | TECH |
BIO-TECHNE Corp
|
32,626 | $2,305,026 |
All Filings in AGEN
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $306 | 100 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $334 | 100 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $314 | 100 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $385 | 100 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $457 | 100 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $151 | 100 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $274 | 100 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $548 | 100 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $1,675 | 100 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,160 | 2,000 | Shares | Defined | 2024-05-15 | |
| 2022-03-31 | $2,459 | 1,000 | Shares | Defined | 2024-08-15 | |
| No filing history on record for this holder in this stock. | ||||||